Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment

Cited by papers we hold 8

• Targeting cytokine and chemokine signaling pathways for cancer therapy · 2024
  No notice
• Breast cancer heterogeneity and its implication in personalized precision therapy · 2023
  Corrected
• CD44 as a tumor biomarker and therapeutic target · 2020
  No notice
• Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells · 2020
  No notice
• Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy · 2019
  No notice
• Mechanisms for estrogen receptor expression in human cancer · 2018
  No notice
• Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors · 2018
  No notice
• Organoid technology and applications in cancer research · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.